Project
Illumina Body Map 2
Navigation
Downloads
Results for MEIS1
Z-value: 1.93
Motif logo
Transcription factors associated with MEIS1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MEIS1
|
ENSG00000143995.15 | Meis homeobox 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MEIS1 | hg19_v2_chr2_+_66666432_66666462 | -0.15 | 4.0e-01 | Click! |
Activity profile of MEIS1 motif
Sorted Z-values of MEIS1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr22_-_36013368 | 10.21 |
ENST00000442617.1
ENST00000397326.2 ENST00000397328.1 ENST00000451685.1 |
MB
|
myoglobin |
| chr21_+_40823753 | 7.79 |
ENST00000333634.4
|
SH3BGR
|
SH3 domain binding glutamic acid-rich protein |
| chr7_+_123295861 | 6.51 |
ENST00000458573.2
ENST00000456238.2 |
LMOD2
|
leiomodin 2 (cardiac) |
| chr6_-_127780510 | 6.44 |
ENST00000487331.2
ENST00000483725.3 |
KIAA0408
|
KIAA0408 |
| chr6_+_53883708 | 5.95 |
ENST00000514921.1
ENST00000274897.5 ENST00000370877.2 |
MLIP
|
muscular LMNA-interacting protein |
| chr6_+_53948221 | 5.80 |
ENST00000460844.2
|
MLIP
|
muscular LMNA-interacting protein |
| chr19_-_45826125 | 5.76 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
| chr6_+_53948328 | 5.74 |
ENST00000370876.2
|
MLIP
|
muscular LMNA-interacting protein |
| chr14_+_32963433 | 5.45 |
ENST00000554410.1
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr1_-_144866711 | 5.25 |
ENST00000530130.1
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr6_+_41021027 | 5.15 |
ENST00000244669.2
|
APOBEC2
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 |
| chr2_+_88367299 | 5.11 |
ENST00000419482.2
ENST00000444564.2 |
SMYD1
|
SET and MYND domain containing 1 |
| chr6_-_123958141 | 5.04 |
ENST00000334268.4
|
TRDN
|
triadin |
| chr14_-_23904861 | 4.91 |
ENST00000355349.3
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta |
| chr13_-_114107839 | 4.89 |
ENST00000375418.3
|
ADPRHL1
|
ADP-ribosylhydrolase like 1 |
| chr4_+_114066764 | 4.86 |
ENST00000511380.1
|
ANK2
|
ankyrin 2, neuronal |
| chr1_-_216978709 | 4.85 |
ENST00000360012.3
|
ESRRG
|
estrogen-related receptor gamma |
| chr2_+_88367368 | 4.59 |
ENST00000438570.1
|
SMYD1
|
SET and MYND domain containing 1 |
| chr19_-_55660561 | 4.53 |
ENST00000587758.1
ENST00000356783.5 ENST00000291901.8 ENST00000588426.1 ENST00000588147.1 ENST00000536926.1 ENST00000588981.1 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr5_+_78985673 | 4.48 |
ENST00000446378.2
|
CMYA5
|
cardiomyopathy associated 5 |
| chr2_-_179672142 | 4.47 |
ENST00000342992.6
ENST00000360870.5 ENST00000460472.2 ENST00000589042.1 ENST00000591111.1 ENST00000342175.6 ENST00000359218.5 |
TTN
|
titin |
| chr2_-_152589670 | 4.39 |
ENST00000604864.1
ENST00000603639.1 |
NEB
|
nebulin |
| chr14_-_94421923 | 4.35 |
ENST00000555507.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr2_-_211179883 | 4.31 |
ENST00000352451.3
|
MYL1
|
myosin, light chain 1, alkali; skeletal, fast |
| chr5_-_172662303 | 4.29 |
ENST00000517440.1
ENST00000329198.4 |
NKX2-5
|
NK2 homeobox 5 |
| chr6_+_53883790 | 4.23 |
ENST00000509997.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr7_-_32111009 | 4.08 |
ENST00000396184.3
ENST00000396189.2 ENST00000321453.7 |
PDE1C
|
phosphodiesterase 1C, calmodulin-dependent 70kDa |
| chr18_+_32398326 | 4.07 |
ENST00000269192.7
ENST00000591182.1 ENST00000597674.1 ENST00000556414.3 |
DTNA
|
dystrobrevin, alpha |
| chr1_+_167063282 | 4.06 |
ENST00000361200.2
|
DUSP27
|
dual specificity phosphatase 27 (putative) |
| chr22_-_36018569 | 4.05 |
ENST00000419229.1
ENST00000406324.1 |
MB
|
myoglobin |
| chr16_+_6533380 | 3.97 |
ENST00000552089.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr1_-_144995074 | 3.94 |
ENST00000534536.1
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr18_+_32455201 | 3.90 |
ENST00000590831.2
|
DTNA
|
dystrobrevin, alpha |
| chr1_-_145039835 | 3.86 |
ENST00000533259.1
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr18_+_32398400 | 3.84 |
ENST00000599844.1
|
DTNA
|
dystrobrevin, alpha |
| chr3_-_12200851 | 3.81 |
ENST00000287814.4
|
TIMP4
|
TIMP metallopeptidase inhibitor 4 |
| chr3_+_173116225 | 3.72 |
ENST00000457714.1
|
NLGN1
|
neuroligin 1 |
| chr10_+_69869237 | 3.70 |
ENST00000373675.3
|
MYPN
|
myopalladin |
| chr5_-_138780159 | 3.67 |
ENST00000512473.1
ENST00000515581.1 ENST00000515277.1 |
DNAJC18
|
DnaJ (Hsp40) homolog, subfamily C, member 18 |
| chr18_+_32397918 | 3.66 |
ENST00000590727.1
ENST00000601125.1 |
DTNA
|
dystrobrevin, alpha |
| chr3_+_35722844 | 3.66 |
ENST00000436702.1
ENST00000438071.1 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr1_-_145039949 | 3.63 |
ENST00000313382.9
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr4_-_65275100 | 3.62 |
ENST00000509536.1
|
TECRL
|
trans-2,3-enoyl-CoA reductase-like |
| chr10_-_21186144 | 3.49 |
ENST00000377119.1
|
NEBL
|
nebulette |
| chr4_-_65275162 | 3.48 |
ENST00000381210.3
ENST00000507440.1 |
TECRL
|
trans-2,3-enoyl-CoA reductase-like |
| chr2_-_50574856 | 3.42 |
ENST00000342183.5
|
NRXN1
|
neurexin 1 |
| chr16_-_46782221 | 3.42 |
ENST00000394809.4
|
MYLK3
|
myosin light chain kinase 3 |
| chr4_-_88450535 | 3.40 |
ENST00000541496.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr1_-_109935819 | 3.39 |
ENST00000538502.1
|
SORT1
|
sortilin 1 |
| chr1_-_144994909 | 3.36 |
ENST00000369347.4
ENST00000369354.3 |
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr10_-_131762105 | 3.35 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
| chr4_-_88450372 | 3.35 |
ENST00000543631.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr22_+_31518938 | 3.33 |
ENST00000412985.1
ENST00000331075.5 ENST00000412277.2 ENST00000420017.1 ENST00000400294.2 ENST00000405300.1 ENST00000404390.3 |
INPP5J
|
inositol polyphosphate-5-phosphatase J |
| chr4_-_88450244 | 3.32 |
ENST00000503414.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr4_-_88450612 | 3.32 |
ENST00000418378.1
ENST00000282470.6 |
SPARCL1
|
SPARC-like 1 (hevin) |
| chr6_-_33714752 | 3.31 |
ENST00000451316.1
|
IP6K3
|
inositol hexakisphosphate kinase 3 |
| chr8_-_107782463 | 3.31 |
ENST00000311955.3
|
ABRA
|
actin-binding Rho activating protein |
| chr18_+_32073839 | 3.29 |
ENST00000590412.1
|
DTNA
|
dystrobrevin, alpha |
| chr7_+_95401851 | 3.28 |
ENST00000447467.2
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
| chr6_-_46293378 | 3.28 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
| chr1_-_144995002 | 3.27 |
ENST00000369356.4
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr1_+_228395755 | 3.26 |
ENST00000284548.11
ENST00000570156.2 ENST00000422127.1 ENST00000366707.4 ENST00000366709.4 |
OBSCN
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
| chr11_-_111794446 | 3.25 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
| chr12_-_111358372 | 3.25 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
| chr3_+_35722487 | 3.24 |
ENST00000441454.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr4_-_88450511 | 3.20 |
ENST00000458304.2
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr20_-_39946237 | 3.18 |
ENST00000441102.2
ENST00000559234.1 |
ZHX3
|
zinc fingers and homeoboxes 3 |
| chr3_-_52488048 | 3.15 |
ENST00000232975.3
|
TNNC1
|
troponin C type 1 (slow) |
| chr18_-_56296182 | 3.09 |
ENST00000361673.3
|
ALPK2
|
alpha-kinase 2 |
| chr4_-_88450595 | 3.05 |
ENST00000434434.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr12_+_21679220 | 3.03 |
ENST00000256969.2
|
C12orf39
|
chromosome 12 open reading frame 39 |
| chr6_-_123957942 | 3.03 |
ENST00000398178.3
|
TRDN
|
triadin |
| chr6_-_123958051 | 3.01 |
ENST00000546248.1
|
TRDN
|
triadin |
| chr4_-_186877806 | 3.00 |
ENST00000355634.5
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr12_+_19358192 | 3.00 |
ENST00000538305.1
|
PLEKHA5
|
pleckstrin homology domain containing, family A member 5 |
| chr11_-_111781554 | 2.93 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
| chr6_+_155537771 | 2.93 |
ENST00000275246.7
|
TIAM2
|
T-cell lymphoma invasion and metastasis 2 |
| chr6_+_118869452 | 2.91 |
ENST00000357525.5
|
PLN
|
phospholamban |
| chr11_-_111781610 | 2.90 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
| chr11_-_119252359 | 2.85 |
ENST00000455332.2
|
USP2
|
ubiquitin specific peptidase 2 |
| chr6_-_123958111 | 2.84 |
ENST00000542443.1
|
TRDN
|
triadin |
| chr11_-_111781454 | 2.82 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
| chr12_-_49393092 | 2.82 |
ENST00000421952.2
|
DDN
|
dendrin |
| chr3_+_35682913 | 2.82 |
ENST00000449196.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr1_-_16344500 | 2.80 |
ENST00000406363.2
ENST00000411503.1 ENST00000545268.1 ENST00000487046.1 |
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular) |
| chr5_-_172662230 | 2.77 |
ENST00000424406.2
|
NKX2-5
|
NK2 homeobox 5 |
| chr17_+_44039704 | 2.76 |
ENST00000420682.2
ENST00000415613.2 ENST00000571987.1 ENST00000574436.1 ENST00000431008.3 |
MAPT
|
microtubule-associated protein tau |
| chr8_-_82359662 | 2.74 |
ENST00000519260.1
ENST00000256103.2 |
PMP2
|
peripheral myelin protein 2 |
| chr6_-_84418841 | 2.74 |
ENST00000369694.2
ENST00000195649.6 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr4_-_168155577 | 2.73 |
ENST00000541354.1
ENST00000509854.1 ENST00000512681.1 ENST00000421836.2 ENST00000510741.1 ENST00000510403.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr6_-_46424599 | 2.70 |
ENST00000405162.1
|
RCAN2
|
regulator of calcineurin 2 |
| chr1_-_145039771 | 2.63 |
ENST00000493130.2
ENST00000532801.1 ENST00000478649.2 |
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr10_-_4285835 | 2.63 |
ENST00000454470.1
|
LINC00702
|
long intergenic non-protein coding RNA 702 |
| chr4_+_166300084 | 2.62 |
ENST00000402744.4
|
CPE
|
carboxypeptidase E |
| chr4_-_186732892 | 2.60 |
ENST00000451958.1
ENST00000439914.1 ENST00000428330.1 ENST00000429056.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr17_+_33474826 | 2.59 |
ENST00000268876.5
ENST00000433649.1 ENST00000378449.1 |
UNC45B
|
unc-45 homolog B (C. elegans) |
| chr9_+_87285539 | 2.58 |
ENST00000359847.3
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
| chr7_-_32110451 | 2.56 |
ENST00000396191.1
ENST00000396182.2 |
PDE1C
|
phosphodiesterase 1C, calmodulin-dependent 70kDa |
| chr12_-_57634475 | 2.55 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr4_+_113739244 | 2.55 |
ENST00000503271.1
ENST00000503423.1 ENST00000506722.1 |
ANK2
|
ankyrin 2, neuronal |
| chr17_+_33474860 | 2.54 |
ENST00000394570.2
|
UNC45B
|
unc-45 homolog B (C. elegans) |
| chr3_-_47934234 | 2.51 |
ENST00000420772.2
|
MAP4
|
microtubule-associated protein 4 |
| chr19_-_48867291 | 2.50 |
ENST00000435956.3
|
TMEM143
|
transmembrane protein 143 |
| chr5_-_172662197 | 2.49 |
ENST00000521848.1
|
NKX2-5
|
NK2 homeobox 5 |
| chr13_+_76413852 | 2.49 |
ENST00000533809.2
|
LMO7
|
LIM domain 7 |
| chr19_-_48867171 | 2.48 |
ENST00000377431.2
ENST00000436660.2 ENST00000541566.1 |
TMEM143
|
transmembrane protein 143 |
| chr6_-_33714667 | 2.47 |
ENST00000293756.4
|
IP6K3
|
inositol hexakisphosphate kinase 3 |
| chr12_+_12938541 | 2.46 |
ENST00000356591.4
|
APOLD1
|
apolipoprotein L domain containing 1 |
| chr7_+_95401877 | 2.46 |
ENST00000524053.1
ENST00000324972.6 ENST00000537881.1 ENST00000437599.1 ENST00000359388.4 ENST00000413338.1 |
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
| chr1_-_11907829 | 2.45 |
ENST00000376480.3
|
NPPA
|
natriuretic peptide A |
| chr5_+_7654057 | 2.45 |
ENST00000537121.1
|
ADCY2
|
adenylate cyclase 2 (brain) |
| chr5_-_16509101 | 2.45 |
ENST00000399793.2
|
FAM134B
|
family with sequence similarity 134, member B |
| chr6_-_84418860 | 2.45 |
ENST00000521743.1
|
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr6_+_163837347 | 2.43 |
ENST00000544436.1
|
QKI
|
QKI, KH domain containing, RNA binding |
| chr4_+_14113592 | 2.43 |
ENST00000502759.1
ENST00000511200.1 ENST00000512754.1 ENST00000506739.1 |
LINC01085
|
long intergenic non-protein coding RNA 1085 |
| chr10_-_61899124 | 2.42 |
ENST00000373815.1
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr11_+_131240373 | 2.40 |
ENST00000374791.3
ENST00000436745.1 |
NTM
|
neurotrimin |
| chr6_-_84418432 | 2.40 |
ENST00000519825.1
ENST00000523484.2 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr1_+_66999799 | 2.40 |
ENST00000371035.3
ENST00000371036.3 ENST00000371037.4 |
SGIP1
|
SH3-domain GRB2-like (endophilin) interacting protein 1 |
| chr9_+_87286997 | 2.39 |
ENST00000395866.2
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
| chr10_+_54074033 | 2.39 |
ENST00000373970.3
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1 |
| chr18_-_21891460 | 2.38 |
ENST00000357041.4
|
OSBPL1A
|
oxysterol binding protein-like 1A |
| chr2_-_100925967 | 2.37 |
ENST00000409647.1
|
LONRF2
|
LON peptidase N-terminal domain and ring finger 2 |
| chr14_+_24540046 | 2.37 |
ENST00000397016.2
ENST00000537691.1 ENST00000560356.1 ENST00000558450.1 |
CPNE6
|
copine VI (neuronal) |
| chr2_-_172750733 | 2.36 |
ENST00000392592.4
ENST00000422440.2 |
SLC25A12
|
solute carrier family 25 (aspartate/glutamate carrier), member 12 |
| chr1_-_144994840 | 2.35 |
ENST00000369351.3
ENST00000369349.3 |
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr16_+_6533729 | 2.34 |
ENST00000551752.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr4_-_88449771 | 2.32 |
ENST00000535835.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr3_+_35722424 | 2.32 |
ENST00000396481.2
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr11_-_41481135 | 2.32 |
ENST00000528697.1
ENST00000530763.1 |
LRRC4C
|
leucine rich repeat containing 4C |
| chrX_+_103029314 | 2.27 |
ENST00000429977.1
|
PLP1
|
proteolipid protein 1 |
| chr10_-_92681033 | 2.27 |
ENST00000371697.3
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle) |
| chr13_-_67802549 | 2.27 |
ENST00000328454.5
ENST00000377865.2 |
PCDH9
|
protocadherin 9 |
| chr20_+_58630972 | 2.25 |
ENST00000313426.1
|
C20orf197
|
chromosome 20 open reading frame 197 |
| chr1_+_166958497 | 2.25 |
ENST00000367870.2
|
MAEL
|
maelstrom spermatogenic transposon silencer |
| chr1_+_169079823 | 2.25 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr3_+_159570722 | 2.23 |
ENST00000482804.1
|
SCHIP1
|
schwannomin interacting protein 1 |
| chr7_-_137028534 | 2.22 |
ENST00000348225.2
|
PTN
|
pleiotrophin |
| chr11_-_31832862 | 2.21 |
ENST00000379115.4
|
PAX6
|
paired box 6 |
| chr1_-_40137710 | 2.21 |
ENST00000235628.1
|
NT5C1A
|
5'-nucleotidase, cytosolic IA |
| chr12_+_19358228 | 2.20 |
ENST00000424268.1
ENST00000543806.1 |
PLEKHA5
|
pleckstrin homology domain containing, family A member 5 |
| chr7_-_44265492 | 2.18 |
ENST00000425809.1
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr7_-_150884332 | 2.17 |
ENST00000275838.1
ENST00000422024.1 ENST00000434669.1 |
ASB10
|
ankyrin repeat and SOCS box containing 10 |
| chr1_+_205012293 | 2.16 |
ENST00000331830.4
|
CNTN2
|
contactin 2 (axonal) |
| chr12_-_56693758 | 2.16 |
ENST00000547298.1
ENST00000551936.1 ENST00000551253.1 ENST00000551473.1 |
CS
|
citrate synthase |
| chr11_-_83393429 | 2.16 |
ENST00000426717.2
|
DLG2
|
discs, large homolog 2 (Drosophila) |
| chr11_-_19262486 | 2.16 |
ENST00000250024.4
|
E2F8
|
E2F transcription factor 8 |
| chr4_-_168155417 | 2.11 |
ENST00000511269.1
ENST00000506697.1 ENST00000512042.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr2_+_173955327 | 2.11 |
ENST00000422149.1
|
MLTK
|
Mitogen-activated protein kinase kinase kinase MLT |
| chr1_+_66999268 | 2.11 |
ENST00000371039.1
ENST00000424320.1 |
SGIP1
|
SH3-domain GRB2-like (endophilin) interacting protein 1 |
| chr1_+_166958346 | 2.10 |
ENST00000367872.4
|
MAEL
|
maelstrom spermatogenic transposon silencer |
| chr19_-_42927251 | 2.09 |
ENST00000597001.1
|
LIPE
|
lipase, hormone-sensitive |
| chr15_+_57884117 | 2.07 |
ENST00000267853.5
|
MYZAP
|
myocardial zonula adherens protein |
| chr11_+_1942580 | 2.06 |
ENST00000381558.1
|
TNNT3
|
troponin T type 3 (skeletal, fast) |
| chr21_+_35552978 | 2.05 |
ENST00000428914.2
ENST00000609062.1 ENST00000609947.1 |
LINC00310
|
long intergenic non-protein coding RNA 310 |
| chr3_+_158787041 | 2.04 |
ENST00000471575.1
ENST00000476809.1 ENST00000485419.1 |
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
| chrX_-_62974941 | 2.03 |
ENST00000374872.1
ENST00000253401.6 ENST00000374870.4 |
ARHGEF9
|
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
| chrX_+_12156582 | 2.03 |
ENST00000380682.1
|
FRMPD4
|
FERM and PDZ domain containing 4 |
| chr3_-_24536222 | 2.03 |
ENST00000415021.1
ENST00000447875.1 |
THRB
|
thyroid hormone receptor, beta |
| chr11_-_30608413 | 2.03 |
ENST00000528686.1
|
MPPED2
|
metallophosphoesterase domain containing 2 |
| chr4_-_101111615 | 2.02 |
ENST00000273990.2
|
DDIT4L
|
DNA-damage-inducible transcript 4-like |
| chr3_+_16216210 | 2.02 |
ENST00000437509.1
|
GALNT15
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
| chr8_-_13372253 | 2.01 |
ENST00000316609.5
|
DLC1
|
deleted in liver cancer 1 |
| chr10_-_4285923 | 2.00 |
ENST00000418372.1
ENST00000608792.1 |
LINC00702
|
long intergenic non-protein coding RNA 702 |
| chr11_-_31832785 | 2.00 |
ENST00000241001.8
|
PAX6
|
paired box 6 |
| chr5_+_43602750 | 2.00 |
ENST00000505678.2
ENST00000512422.1 ENST00000264663.5 |
NNT
|
nicotinamide nucleotide transhydrogenase |
| chr18_+_59000815 | 1.99 |
ENST00000262717.4
|
CDH20
|
cadherin 20, type 2 |
| chr3_+_135741576 | 1.96 |
ENST00000334546.2
|
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha |
| chr3_-_58613323 | 1.95 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
| chr10_-_97200772 | 1.95 |
ENST00000371241.1
ENST00000354106.3 ENST00000371239.1 ENST00000361941.3 ENST00000277982.5 ENST00000371245.3 |
SORBS1
|
sorbin and SH3 domain containing 1 |
| chr1_+_165513231 | 1.95 |
ENST00000294818.1
|
LRRC52
|
leucine rich repeat containing 52 |
| chr10_+_18240834 | 1.93 |
ENST00000377371.3
ENST00000539911.1 |
SLC39A12
|
solute carrier family 39 (zinc transporter), member 12 |
| chr6_-_163148700 | 1.93 |
ENST00000366894.1
ENST00000338468.3 |
PARK2
|
parkin RBR E3 ubiquitin protein ligase |
| chr11_-_30607819 | 1.92 |
ENST00000448418.2
|
MPPED2
|
metallophosphoesterase domain containing 2 |
| chr6_+_39760783 | 1.91 |
ENST00000398904.2
ENST00000538976.1 |
DAAM2
|
dishevelled associated activator of morphogenesis 2 |
| chr11_-_31832685 | 1.89 |
ENST00000438681.1
|
PAX6
|
paired box 6 |
| chr7_-_150884873 | 1.89 |
ENST00000377867.3
|
ASB10
|
ankyrin repeat and SOCS box containing 10 |
| chr3_-_155011483 | 1.88 |
ENST00000489090.1
|
RP11-451G4.2
|
RP11-451G4.2 |
| chr7_+_136553370 | 1.87 |
ENST00000445907.2
|
CHRM2
|
cholinergic receptor, muscarinic 2 |
| chr20_+_5892147 | 1.86 |
ENST00000455042.1
|
CHGB
|
chromogranin B (secretogranin 1) |
| chr4_-_186877502 | 1.86 |
ENST00000431902.1
ENST00000284776.7 ENST00000415274.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr6_-_163148780 | 1.86 |
ENST00000366892.1
ENST00000366898.1 ENST00000366897.1 ENST00000366896.1 |
PARK2
|
parkin RBR E3 ubiquitin protein ligase |
| chr3_+_16216137 | 1.86 |
ENST00000339732.5
|
GALNT15
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
| chr6_+_155538093 | 1.85 |
ENST00000462408.2
|
TIAM2
|
T-cell lymphoma invasion and metastasis 2 |
| chr20_+_44036900 | 1.84 |
ENST00000443296.1
|
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
| chr3_+_173115520 | 1.84 |
ENST00000413821.1
|
NLGN1
|
neuroligin 1 |
| chr13_+_76378305 | 1.84 |
ENST00000526371.1
ENST00000526528.1 |
LMO7
|
LIM domain 7 |
| chr4_+_75858318 | 1.83 |
ENST00000307428.7
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
| chr10_+_18240753 | 1.83 |
ENST00000377369.2
|
SLC39A12
|
solute carrier family 39 (zinc transporter), member 12 |
| chr6_-_56507586 | 1.83 |
ENST00000439203.1
ENST00000518935.1 ENST00000446842.2 ENST00000370765.6 ENST00000244364.6 |
DST
|
dystonin |
| chr3_+_35721182 | 1.83 |
ENST00000413378.1
ENST00000417925.1 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr2_+_16080659 | 1.81 |
ENST00000281043.3
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog |
| chr12_+_26348246 | 1.81 |
ENST00000422622.2
|
SSPN
|
sarcospan |
| chr17_+_48609903 | 1.81 |
ENST00000268933.3
|
EPN3
|
epsin 3 |
| chr5_-_176057365 | 1.81 |
ENST00000310112.3
|
SNCB
|
synuclein, beta |
| chr5_-_136649218 | 1.81 |
ENST00000510405.1
|
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
| chr10_-_62332357 | 1.80 |
ENST00000503366.1
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr6_-_84417633 | 1.79 |
ENST00000521931.1
|
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr11_-_31832581 | 1.78 |
ENST00000379111.2
|
PAX6
|
paired box 6 |
| chr8_-_70747205 | 1.78 |
ENST00000260126.4
|
SLCO5A1
|
solute carrier organic anion transporter family, member 5A1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of MEIS1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.5 | 13.9 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
| 3.2 | 9.5 | GO:0003168 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 2.6 | 23.7 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 2.1 | 12.4 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 1.4 | 5.6 | GO:0098942 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 1.3 | 3.9 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
| 1.2 | 9.7 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 1.1 | 4.4 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 1.1 | 3.2 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 1.0 | 7.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 1.0 | 3.0 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 1.0 | 7.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 1.0 | 2.9 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 1.0 | 2.9 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.9 | 4.7 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.9 | 2.8 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.9 | 2.8 | GO:0048174 | negative regulation of short-term neuronal synaptic plasticity(GO:0048174) |
| 0.9 | 6.2 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.9 | 4.4 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.8 | 5.0 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.8 | 2.4 | GO:0100012 | regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.8 | 3.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.7 | 4.2 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
| 0.7 | 4.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.7 | 0.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.7 | 7.9 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.6 | 4.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.6 | 4.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.6 | 2.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.6 | 1.8 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 0.6 | 1.7 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.6 | 2.3 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.6 | 1.7 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.6 | 2.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.6 | 2.2 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.5 | 2.2 | GO:0060168 | regulation of axon diameter(GO:0031133) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.5 | 2.6 | GO:0030070 | insulin processing(GO:0030070) |
| 0.5 | 5.2 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.5 | 5.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.5 | 3.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.5 | 1.4 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.5 | 1.9 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.5 | 5.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.5 | 11.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.5 | 2.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.4 | 1.3 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.4 | 7.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.4 | 4.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.4 | 3.4 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.4 | 4.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.4 | 1.1 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.4 | 4.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.4 | 2.3 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.4 | 1.1 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.4 | 2.5 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.4 | 20.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.4 | 1.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.4 | 3.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 | 1.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.3 | 3.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.3 | 5.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.3 | 3.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.3 | 4.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.3 | 1.6 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.3 | 1.6 | GO:0060578 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
| 0.3 | 0.3 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
| 0.3 | 3.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.3 | 12.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.3 | 1.4 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.3 | 10.8 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.3 | 0.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.3 | 13.3 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 | 0.8 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.3 | 1.1 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.3 | 1.1 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.3 | 1.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.3 | 2.4 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.3 | 1.9 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.3 | 1.1 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
| 0.3 | 1.0 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.3 | 2.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 4.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 1.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.2 | 5.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.2 | 0.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.2 | 1.0 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.2 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.2 | 5.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 3.8 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.2 | 0.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 | 0.9 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.2 | 1.6 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 | 0.7 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.2 | 3.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 | 0.9 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.2 | 0.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 | 0.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 | 6.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 1.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.2 | 4.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.2 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 0.6 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.2 | 1.9 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.2 | 1.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.2 | 0.8 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.2 | 0.6 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.2 | 0.8 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.2 | 0.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.2 | 0.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.2 | 0.6 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
| 0.2 | 1.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 | 0.8 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.2 | 4.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 | 1.4 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.2 | 1.4 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.2 | 3.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.2 | 1.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.2 | 0.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.2 | 8.5 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.2 | 4.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 0.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.2 | 1.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 | 3.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 | 0.4 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.2 | 0.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.2 | 1.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.2 | 2.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.2 | 0.5 | GO:1903217 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.2 | 1.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.2 | 2.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.2 | 0.5 | GO:1903371 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.2 | 1.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 1.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.2 | 1.7 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 0.2 | 1.0 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 0.2 | 4.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.2 | 2.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.2 | 0.9 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.2 | 0.5 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.2 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.2 | 1.1 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.2 | 1.1 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 | 2.0 | GO:0030091 | protein repair(GO:0030091) |
| 0.2 | 1.2 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.2 | 6.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.2 | 1.8 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.1 | 1.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 | 0.1 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 0.1 | 0.3 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.1 | 0.7 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 | 1.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 | 1.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 1.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.1 | 2.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 0.7 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.1 | 1.0 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 | 1.1 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 | 1.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 0.1 | 3.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 5.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 1.1 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 | 2.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 | 1.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 0.5 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.1 | 0.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 2.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.1 | 2.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.9 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 0.5 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.1 | 1.3 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 3.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 1.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.1 | 0.5 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 0.7 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 | 7.3 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 1.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.5 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 | 0.6 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 0.6 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.1 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
| 0.1 | 3.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 | 1.4 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.1 | 0.3 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.1 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 0.5 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.1 | 2.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 1.8 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 | 1.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.1 | 1.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 0.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.1 | 0.5 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 | 1.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.6 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.1 | 0.7 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.1 | 1.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 | 1.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 3.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 1.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.1 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.1 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.4 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 7.3 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.1 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 | 3.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.1 | 1.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 0.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 | 0.7 | GO:0060677 | ureteric bud elongation(GO:0060677) |
| 0.1 | 2.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 1.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 0.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 | 0.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 | 3.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
| 0.1 | 1.0 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.1 | 0.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.1 | 0.9 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 | 0.4 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.1 | 1.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.1 | 1.4 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 | 1.4 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 1.2 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.1 | 1.0 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 | 0.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 3.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 1.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.1 | 0.6 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.1 | 0.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 | 2.4 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 | 0.8 | GO:0042262 | DNA protection(GO:0042262) |
| 0.1 | 0.2 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.1 | 0.7 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 | 0.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 1.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.8 | GO:0099639 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.1 | 1.0 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.1 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 | 0.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 | 1.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 0.9 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 | 1.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 3.7 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.1 | 0.3 | GO:0070894 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.1 | 0.7 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.1 | 1.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 2.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 | 14.5 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.1 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.1 | 0.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.9 | GO:0051964 | netrin-activated signaling pathway(GO:0038007) negative regulation of synapse assembly(GO:0051964) |
| 0.1 | 0.7 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.1 | 0.3 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 6.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.1 | 1.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 0.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.7 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 1.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.1 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 0.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 | 2.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.5 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.1 | 0.6 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.1 | 0.4 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.1 | 1.7 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.1 | 0.4 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 0.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.1 | 1.3 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
| 0.1 | 0.4 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 1.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.1 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 | 1.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 | 5.0 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.1 | 1.4 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 0.4 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.1 | 1.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.1 | 2.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 0.1 | 0.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 4.0 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 1.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 | 0.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.1 | 0.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 1.8 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.1 | 1.8 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.0 | 1.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.0 | 0.7 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.0 | 0.9 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 1.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.0 | 2.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 0.2 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
| 0.0 | 3.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 3.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.0 | 0.5 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.0 | 1.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 | 0.2 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.0 | 8.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.3 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.0 | 0.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.0 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 | 1.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.0 | 0.6 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.6 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.0 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
| 0.0 | 3.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 1.4 | GO:0016246 | RNA interference(GO:0016246) |
| 0.0 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.0 | 2.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.0 | 0.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 | 0.5 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 2.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.2 | GO:0048840 | otolith development(GO:0048840) |
| 0.0 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 | 1.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.0 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 | 1.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 | 0.1 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 | 1.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 3.4 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.0 | 3.1 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.6 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
| 0.0 | 0.3 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.0 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.0 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.0 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.0 | 1.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.0 | 4.2 | GO:0030010 | establishment of cell polarity(GO:0030010) |
| 0.0 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.2 | GO:1904753 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
| 0.0 | 0.7 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.0 | 0.3 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.0 | 1.3 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
| 0.0 | 0.2 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.0 | 0.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 1.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.0 | 0.2 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 0.0 | 1.4 | GO:0048806 | genitalia development(GO:0048806) |
| 0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.0 | 0.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 1.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.2 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 | 1.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.4 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.0 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 | 0.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 0.1 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 | 0.3 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 0.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) oligosaccharide catabolic process(GO:0009313) |
| 0.0 | 0.4 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
| 0.0 | 0.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.9 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.0 | 0.1 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.0 | 1.1 | GO:0006536 | glutamate metabolic process(GO:0006536) |
| 0.0 | 0.2 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 | 0.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 0.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.0 | 0.6 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.0 | 0.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 0.1 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.0 | 0.7 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.0 | 0.3 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 | 15.3 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.0 | 0.8 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
| 0.0 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.0 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.0 | 2.9 | GO:0008016 | regulation of heart contraction(GO:0008016) |
| 0.0 | 0.2 | GO:2000096 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 2.5 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.0 | 0.6 | GO:0006413 | translational initiation(GO:0006413) |
| 0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.0 | 0.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.0 | 0.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.0 | 0.2 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.0 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.0 | 0.4 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.0 | 0.5 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 1.3 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.1 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 0.0 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.2 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.0 | 0.6 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.0 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 | 0.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.0 | 0.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.0 | 1.1 | GO:0000045 | autophagosome assembly(GO:0000045) |
| 0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 | 0.1 | GO:0045046 | peroxisome membrane biogenesis(GO:0016557) protein import into peroxisome membrane(GO:0045046) |
| 0.0 | 0.1 | GO:1901906 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.0 | 0.4 | GO:0060047 | heart contraction(GO:0060047) |
| 0.0 | 0.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.7 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.0 | 0.4 | GO:0060324 | face development(GO:0060324) |
| 0.0 | 0.4 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
| 0.0 | 0.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.0 | 1.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.0 | 0.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.0 | 0.6 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 1.9 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.0 | 0.2 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.0 | 0.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 1.2 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
| 0.0 | 2.0 | GO:0006936 | muscle contraction(GO:0006936) |
| 0.0 | 0.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.0 | 0.4 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.0 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.0 | 0.5 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.0 | 0.5 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.0 | 0.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 0.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 | 0.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 | 0.7 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.0 | 0.1 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
| 0.0 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.0 | 0.5 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 1.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.0 | 0.4 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.1 | GO:1900045 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.0 | 0.2 | GO:0060004 | reflex(GO:0060004) |
| 0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 | 1.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 4.4 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 1.5 | 6.1 | GO:0030849 | autosome(GO:0030849) |
| 1.1 | 19.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.8 | 15.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.6 | 1.7 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
| 0.6 | 2.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.5 | 5.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.5 | 5.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.5 | 29.4 | GO:0031430 | M band(GO:0031430) |
| 0.4 | 0.9 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.4 | 11.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.4 | 2.8 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.4 | 1.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.4 | 6.6 | GO:0005861 | troponin complex(GO:0005861) |
| 0.4 | 1.1 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
| 0.3 | 1.8 | GO:0031673 | H zone(GO:0031673) |
| 0.3 | 2.7 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.3 | 4.1 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.3 | 2.0 | GO:0043005 | neuron projection(GO:0043005) |
| 0.3 | 1.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.3 | 1.5 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.2 | 0.7 | GO:0044299 | C-fiber(GO:0044299) |
| 0.2 | 0.5 | GO:0097208 | alveolar lamellar body(GO:0097208) lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.2 | 89.2 | GO:0030016 | myofibril(GO:0030016) |
| 0.2 | 3.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.2 | 0.7 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.2 | 8.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.2 | 5.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 3.0 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.2 | 3.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 6.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.2 | 2.5 | GO:0016342 | catenin complex(GO:0016342) |
| 0.2 | 1.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.2 | 4.6 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.2 | 2.5 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 1.7 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.2 | 0.7 | GO:1990075 | kinesin II complex(GO:0016939) periciliary membrane compartment(GO:1990075) |
| 0.2 | 4.8 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 5.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.1 | 20.1 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.1 | 16.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 4.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 7.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.8 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.1 | 2.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 1.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.1 | 1.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 1.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 0.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.1 | 0.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.1 | 4.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.1 | 1.2 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.1 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.1 | 19.9 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 3.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.6 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.1 | 1.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 1.9 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 1.5 | GO:0030054 | cell junction(GO:0030054) |
| 0.1 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.1 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.1 | 1.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 5.4 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 1.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 1.1 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 2.7 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.1 | 0.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 1.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
| 0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 0.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.1 | 2.3 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 5.6 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.1 | 28.5 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.1 | 0.8 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 0.2 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.1 | 0.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 1.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 1.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 30.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.1 | 2.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 3.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 2.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 1.6 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 0.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.0 | 2.9 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
| 0.0 | 4.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 4.0 | GO:0012505 | endomembrane system(GO:0012505) |
| 0.0 | 6.2 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.0 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.0 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 1.1 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.0 | 1.5 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.0 | 0.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.0 | 1.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 1.9 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.0 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.0 | 1.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 0.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.0 | 9.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.0 | 4.7 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 2.4 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 2.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.0 | 1.0 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 0.2 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.0 | 0.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.0 | 2.1 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.0 | 0.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 2.9 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 17.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.0 | 2.1 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.0 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 0.1 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 2.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.0 | 1.7 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.5 | GO:0000800 | lateral element(GO:0000800) |
| 0.0 | 0.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.0 | 0.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 2.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.2 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 8.0 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.0 | 2.5 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 0.3 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.6 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 1.4 | GO:0098794 | postsynapse(GO:0098794) |
| 0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 1.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.7 | GO:0005657 | replication fork(GO:0005657) |
| 0.0 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.0 | 0.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.0 | 1.2 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.0 | 2.3 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.0 | 0.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.0 | 0.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 2.0 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.0 | 0.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.0 | 0.9 | GO:0005875 | microtubule associated complex(GO:0005875) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 9.5 | GO:0010736 | serum response element binding(GO:0010736) |
| 1.8 | 5.4 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 1.0 | 3.1 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 1.0 | 4.9 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 1.0 | 7.8 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 1.0 | 3.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.0 | 4.8 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 1.0 | 2.9 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.9 | 6.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.8 | 5.0 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.8 | 7.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.8 | 2.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.7 | 7.3 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.7 | 3.6 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 0.7 | 2.8 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.7 | 2.8 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.7 | 14.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.7 | 3.4 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.6 | 6.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.6 | 1.7 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.6 | 5.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.5 | 5.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.5 | 1.5 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.5 | 11.2 | GO:0031432 | titin binding(GO:0031432) |
| 0.5 | 13.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.5 | 2.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.5 | 1.8 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.4 | 1.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.4 | 13.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.4 | 2.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.4 | 1.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.4 | 16.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.4 | 1.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.4 | 1.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.3 | 3.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.3 | 7.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.3 | 1.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.3 | 3.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.3 | 2.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.3 | 3.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.3 | 10.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.3 | 7.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.3 | 4.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 2.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.3 | 4.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.3 | 2.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.3 | 8.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.3 | 10.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.3 | 1.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.3 | 0.9 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.3 | 1.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.3 | 0.8 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.3 | 2.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.3 | 3.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.3 | 5.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.3 | 3.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.3 | 4.0 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.3 | 1.1 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.3 | 1.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.3 | 0.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.3 | 1.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.2 | 1.0 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 0.2 | 2.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.2 | 1.0 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.2 | 13.7 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 0.7 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.2 | 6.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.2 | 1.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.2 | 21.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.2 | 0.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.2 | 1.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.2 | 0.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 1.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.2 | 1.0 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.2 | 2.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.2 | 1.1 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.2 | 0.9 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.2 | 2.5 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.2 | 1.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.2 | 1.0 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.2 | 0.7 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.2 | 1.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.2 | 1.3 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.2 | 3.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.2 | 0.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.2 | 1.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.2 | 0.9 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.2 | 1.1 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.2 | 1.1 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.2 | 1.4 | GO:0042835 | BRE binding(GO:0042835) |
| 0.2 | 8.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 3.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.1 | 2.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.1 | 2.2 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 3.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.1 | 1.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.1 | 1.0 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
| 0.1 | 21.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 1.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.1 | 5.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.9 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.1 | 1.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.1 | 0.4 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.1 | 2.3 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 0.5 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 0.9 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.1 | 3.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 1.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.1 | 0.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.1 | 10.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 4.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.1 | 2.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.1 | 1.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 5.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.7 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.1 | 2.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.1 | 1.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 0.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 0.4 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.1 | 1.1 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 26.3 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 0.9 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.1 | 0.4 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.1 | 0.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 0.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.1 | 0.7 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.1 | 1.5 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 2.8 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 3.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 3.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 1.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 3.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 1.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 2.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.1 | 0.5 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.1 | 0.7 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.1 | 1.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 2.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 2.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 2.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.1 | 0.8 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 3.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 1.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 1.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 0.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.1 | 21.2 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.1 | 2.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 0.6 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 0.4 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.1 | 7.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.1 | 3.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 1.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 1.4 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 1.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 1.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 0.6 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 1.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.1 | 3.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 6.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.1 | 0.2 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 0.1 | 0.4 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.1 | 0.2 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.1 | 0.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.1 | 1.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.1 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 2.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.1 | 1.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 0.7 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 0.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.1 | 1.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 0.3 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 0.1 | 0.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.1 | 0.5 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.1 | 3.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 1.9 | GO:0071949 | FAD binding(GO:0071949) |
| 0.1 | 1.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 2.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.2 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.1 | 2.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 12.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 2.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 1.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 0.2 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.1 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 0.3 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.1 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.1 | 6.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.1 | 2.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 1.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 3.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 2.0 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.1 | 0.6 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 1.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 2.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.0 | 0.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.0 | 0.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.0 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 2.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 0.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.0 | 0.5 | GO:0022821 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
| 0.0 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 1.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.0 | 1.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.0 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 2.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.0 | 1.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.0 | 0.2 | GO:0016312 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol bisphosphate phosphatase activity(GO:0016312) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.0 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.0 | 2.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.5 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 0.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 0.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.0 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.3 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 0.0 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.0 | 1.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.0 | 1.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
| 0.0 | 1.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 2.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 4.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.3 | GO:0016918 | retinal binding(GO:0016918) |
| 0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
| 0.0 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.0 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 1.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 1.5 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.0 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 0.6 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.0 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.0 | 1.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.0 | 1.2 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 1.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 0.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.0 | 0.8 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.0 | 0.3 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.0 | 0.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.0 | 1.4 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 2.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 2.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 1.4 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.0 | 0.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 2.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) protein-disulfide reductase activity(GO:0047134) |
| 0.0 | 0.5 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 0.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.0 | 0.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.0 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.0 | 0.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.0 | 0.1 | GO:0052843 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.0 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.0 | 0.8 | GO:0008168 | methyltransferase activity(GO:0008168) |
| 0.0 | 3.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
| 0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 1.3 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.4 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 0.0 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
| 0.0 | 0.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
| 0.0 | 0.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.1 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.0 | 0.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.0 | 0.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.0 | 0.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.0 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 1.0 | GO:0022832 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
| 0.0 | 1.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 7.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.0 | 3.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 1.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 1.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 2.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 3.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 6.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 2.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 3.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 3.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 3.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 2.5 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 2.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 4.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 2.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 2.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 1.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 2.4 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 1.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 4.2 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 2.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 3.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 17.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 5.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 3.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 5.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 4.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 1.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 2.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 4.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 4.6 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 3.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 1.1 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 1.4 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.0 | 1.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.0 | 1.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.0 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 8.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.3 | 10.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.3 | 23.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.3 | 2.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.3 | 7.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 7.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 4.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 2.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 3.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.1 | 2.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 4.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.1 | 2.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 3.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 3.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
| 0.1 | 5.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 2.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 1.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 1.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 2.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 1.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 6.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 2.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 7.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 0.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.1 | 2.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 4.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 3.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 2.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 1.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.1 | 8.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 4.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.0 | 1.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.7 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.0 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 1.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.0 | 0.9 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.0 | 1.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 3.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 3.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 1.7 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 1.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 3.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.0 | 1.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.0 | 1.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 3.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 1.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 0.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 1.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.0 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 1.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
| 0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.0 | 1.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.0 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 1.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 1.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 7.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.0 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 1.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 0.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 1.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 1.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.0 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.0 | 1.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 0.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.6 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |